H
Helmy Eltoukhy
Researcher at Illumina
Publications - 65
Citations - 3075
Helmy Eltoukhy is an academic researcher from Illumina. The author has contributed to research in topics: Cancer & Nucleic acid. The author has an hindex of 21, co-authored 65 publications receiving 2700 citations. Previous affiliations of Helmy Eltoukhy include Stanford University.
Papers
More filters
Journal ArticleDOI
CMOS image sensors
A. El Gamal,Helmy Eltoukhy +1 more
TL;DR: This article provides a basic introduction to CMOS image-sensor technology, design and performance limits and presents recent developments and future research directions enabled by pixel-level processing, which promise to further improveCMOS image sensor performance and broaden their applicability beyond current markets.
Journal ArticleDOI
Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
Richard B. Lanman,Stefanie Mortimer,Oliver A. Zill,Dragan Sebisanovic,Rene Lopez,Sibel Blau,Eric A. Collisson,Stephen G. Divers,Dave S.B. Hoon,E. Scott Kopetz,Jeeyun Lee,Petros Nikolinakos,Arthur Baca,Bahram G. Kermani,Helmy Eltoukhy,Amir Ali Talasaz +15 more
TL;DR: The analytic and clinical validation of the gene panel are reported and near-perfect analytic specificity enables complete coverage of many genes without the false positives typically seen with traditional sequencing assays at mutant allele frequencies or fractions below 5%.
Journal ArticleDOI
Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- And Plasma-Based Methodologies
Justin I. Odegaard,John J. Vincent,Stefanie Mortimer,James V. Vowles,Bryan C. Ulrich,Kimberly C. Banks,Stephen R. Fairclough,Oliver A. Zill,Marcin Sikora,Reza Bayat Mokhtari,Diana Abdueva,Rebecca J. Nagy,Christine E. Lee,Lesli A. Kiedrowski,Cloud P. Paweletz,Helmy Eltoukhy,Richard B. Lanman,Darya Chudova,AmirAli Talasaz +18 more
TL;DR: High concordance with orthogonal clinical plasma- and tissue-based genotyping methods supports the clinical accuracy of digital sequencing across all four types of targetable genomic alterations.
Journal ArticleDOI
The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients
Oliver A. Zill,Kimberly C. Banks,Stephen R. Fairclough,Stefanie Mortimer,James V. Vowles,Reza Mokhtari,David R. Gandara,Philip C. Mack,Justin I. Odegaard,Rebecca J. Nagy,Arthur Baca,Helmy Eltoukhy,Darya Chudova,Richard B. Lanman,AmirAli Talasaz +14 more
TL;DR: Together, these retrospective analyses of a large cfDNA sequencing data set reveal subclonal structures and emerging resistance in advanced solid tumors.
Journal ArticleDOI
A 0.18-/spl mu/m CMOS bioluminescence detection lab-on-chip
TL;DR: In this paper, the authors describe a bioluminescence detection lab-on-chip consisting of a fiber-optic faceplate with immobilized luminescent reporters/probes that is directly coupled to an optical detection and processing CMOS system on-chip (SoC).